Peter Joyce is the founder of Grey Wolf Therapeutics. Grey Wolf Therapeutics has raised $131M in total funding. Latest round: Series B.
Peter Joyce is the CEO and Co-founder of Grey Wolf Therapeutics, a clinical-stage biotechnology company focused on immuno-oncology therapies. He has guided the company through successful Series A and B financing rounds, leading to its progression into the clinical stage.
Full founder directory · Investor directory · Company funding database · Fundraising library